Exo is pioneering a high-performance handheld ultrasound platform and AI for imaging and therapeutic applications. Exo is committed to delivering affordable and easy-to-use medical imaging to healthcare professionals around the world. By delivering easy-to-use, high quality medical imaging, Exo will empower healthcare professionals to make critical, real-time decisions that improve patient outcomes
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/05/19 | $35,000,000 | Series B |
Applied Ventures Bold Capital Creative Ventures Intel Capital  Longevity Vision Fund Magnetar Capital Nautilus Venture Partners OSF Healthcare Rising Tide Fund Sony Innovation Fund Wanxiang America Healthcare Investments | undisclosed |
| 08/24/20 | $40,000,000 | Series B Extension |
Action Potential Venture Capital Applied Ventures Bold Capital Fiscus Ventures Intel Capital Longevity Vision Fund Nautilus Venture Partners OSF Healthcare Reimagined Ventures Rising Tide Fund Solasta Ventures TDK Ventures | undisclosed |
| 07/29/21 | $220,000,000 | Series C |
Avidity Partners BlackRock Pura Vida Investments RA Capital Management Sands Capital | undisclosed |
